| Emittent | Gattung | Typ | CUSIP/ISIN | Richtung | Bewertungsbasis | Handel | Bestand ($) | % NAV | Stück / Nennwert |
|---|---|---|---|---|---|---|---|---|---|
| Gesamt | 2.667.948.682 $ | 99,63 | 18.131.099 | ||||||
| Eli Lilly and Company | Eli Lilly and Company | EC | 532457108 | Long | Börsenkurs (Stufe 1) | 395.594.803 $ | 14,77 | 329.819 | |
| Johnson & Johnson | Johnson & Johnson | EC | 478160104 | Long | Börsenkurs (Stufe 1) | 251.891.002 $ | 9,41 | 991.814 | |
| AbbVie Inc. | AbbVie Inc. | EC | 00287Y109 | Long | Börsenkurs (Stufe 1) | 183.045.956 $ | 6,84 | 727.412 | |
| UnitedHealth Group Incorporated | UnitedHealth Group Incorporated | EC | 91324P102 | Long | Börsenkurs (Stufe 1) | 155.185.436 $ | 5,79 | 373.374 | |
| Merck & Co., Inc. | Merck & Co., Inc. | EC | 58933Y105 | Long | Börsenkurs (Stufe 1) | 127.068.896 $ | 4,75 | 988.863 | |
| Amgen Inc. | Amgen Inc. | EC | 031162100 | Long | Börsenkurs (Stufe 1) | 80.197.630 $ | 2,99 | 221.467 | |
| Thermo Fisher Scientific Inc. | Thermo Fisher Scientific Inc. | EC | 883556102 | Long | Börsenkurs (Stufe 1) | 76.763.230 $ | 2,87 | 153.110 | |
| Abbott Laboratories | Abbott Laboratories | EC | 002824100 | Long | Börsenkurs (Stufe 1) | 65.002.779 $ | 2,43 | 716.363 | |
| Gilead Sciences, Inc. | Gilead Sciences, Inc. | EC | 375558103 | Long | Börsenkurs (Stufe 1) | 64.580.965 $ | 2,41 | 511.168 | |
| Intuitive Surgical, Inc. | Intuitive Surgical, Inc. | EC | 46120E602 | Long | Börsenkurs (Stufe 1) | 57.792.448 $ | 2,16 | 145.324 | |
| Pfizer Inc. | Pfizer Inc. | EC | 717081103 | Long | Börsenkurs (Stufe 1) | 56.222.923 $ | 2,10 | 2.334.839 | |
| CVS Health Corporation | CVS Health Corporation | EC | 126650100 | Long | Börsenkurs (Stufe 1) | 53.863.725 $ | 2,01 | 520.674 | |
| Vertex Pharmaceuticals Incorporated | Vertex Pharmaceuticals Incorporated | EC | 92532F100 | Long | Börsenkurs (Stufe 1) | 51.873.017 $ | 1,94 | 104.429 | |
| Danaher Corporation | Danaher Corporation | EC | 235851102 | Long | Börsenkurs (Stufe 1) | 50.555.487 $ | 1,89 | 265.411 | |
| Bristol-Myers Squibb Company | Bristol-Myers Squibb Company | EC | 110122108 | Long | Börsenkurs (Stufe 1) | 48.304.747 $ | 1,80 | 838.333 | |
| Stryker Corporation | Stryker Corporation | EC | 863667101 | Long | Börsenkurs (Stufe 1) | 46.873.694 $ | 1,75 | 148.881 | |
| Medtronic, Inc. | Medtronic, Inc. | EC | IE00BTN1Y115 | Long | Börsenkurs (Stufe 1) | 41.336.419 $ | 1,54 | 528.396 | |
| McKesson Corporation | McKesson Corporation | EC | 58155Q103 | Long | Börsenkurs (Stufe 1) | 37.421.090 $ | 1,40 | 49.525 | |
| Elevance Health, Inc. | Elevance Health, Inc. | EC | 036752103 | Long | Börsenkurs (Stufe 1) | 33.321.430 $ | 1,24 | 86.162 | |
| Cigna Group, The | Cigna Group, The | EC | 125523100 | Long | Börsenkurs (Stufe 1) | 28.877.480 $ | 1,08 | 104.750 | |
| Boston Scientific Corporation | Boston Scientific Corporation | EC | 101137107 | Long | Börsenkurs (Stufe 1) | 25.989.175 $ | 0,97 | 608.931 | |
| Regeneron Pharmaceuticals, Inc. | Regeneron Pharmaceuticals, Inc. | EC | 75886F107 | Long | Börsenkurs (Stufe 1) | 25.870.051 $ | 0,97 | 41.489 | |
| HCA Healthcare, Inc. | HCA Healthcare, Inc. | EC | 40412C101 | Long | Börsenkurs (Stufe 1) | 24.161.093 $ | 0,90 | 61.969 | |
| Cardinal Health, Inc. | Cardinal Health, Inc. | EC | 14149Y108 | Long | Börsenkurs (Stufe 1) | 22.900.309 $ | 0,86 | 96.398 | |
| Cencora, Inc. | Cencora, Inc. | EC | 03073E105 | Long | Börsenkurs (Stufe 1) | 22.514.172 $ | 0,84 | 79.561 | |
| Edwards Lifesciences Corporation | Edwards Lifesciences Corporation | EC | 28176E108 | Long | Börsenkurs (Stufe 1) | 20.676.171 $ | 0,77 | 228.567 | |
| Humana Inc. | Humana Inc. | EC | 444859102 | Long | Börsenkurs (Stufe 1) | 19.677.882 $ | 0,73 | 49.539 | |
| Becton, Dickinson and Company | Becton, Dickinson and Company | EC | 075887109 | Long | Börsenkurs (Stufe 1) | 17.162.184 $ | 0,64 | 113.409 | |
| Alnylam Pharmaceuticals, Inc. | Alnylam Pharmaceuticals, Inc. | EC | 02043Q107 | Long | Börsenkurs (Stufe 1) | 16.454.300 $ | 0,61 | 54.660 | |
| IDEXX Laboratories, Inc. | IDEXX Laboratories, Inc. | EC | 45168D104 | Long | Börsenkurs (Stufe 1) | 16.416.505 $ | 0,61 | 31.184 | |
| Agilent Technologies, Inc. | Agilent Technologies, Inc. | EC | 00846U101 | Long | Börsenkurs (Stufe 1) | 15.607.791 $ | 0,58 | 117.502 | |
| Natera, Inc. | Natera, Inc. | EC | 632307104 | Long | Börsenkurs (Stufe 1) | 15.260.919 $ | 0,57 | 56.220 | |
| Waters Corporation | Waters Corporation | EC | 941848103 | Long | Börsenkurs (Stufe 1) | 15.137.938 $ | 0,57 | 40.364 | |
| Revolution Medicines, Inc. | Revolution Medicines, Inc. | EC | 76155X100 | Long | Börsenkurs (Stufe 1) | 14.229.534 $ | 0,53 | 75.980 | |
| IQVIA Holdings Inc | IQVIA Holdings Inc | EC | 46266C105 | Long | Börsenkurs (Stufe 1) | 13.137.221 $ | 0,49 | 67.991 | |
| Biogen Inc. | Biogen Inc. | EC | 09062X103 | Long | Börsenkurs (Stufe 1) | 13.052.833 $ | 0,49 | 60.413 | |
| Centene Corporation | Centene Corporation | EC | 15135B101 | Long | Börsenkurs (Stufe 1) | 13.031.684 $ | 0,49 | 203.017 | |
| Zoetis Inc. | Zoetis Inc. | EC | 98978V103 | Long | Börsenkurs (Stufe 1) | 12.421.217 $ | 0,46 | 172.853 | |
| GE HealthCare Technologies Inc. | GE HealthCare Technologies Inc. | EC | 36266G107 | Long | Börsenkurs (Stufe 1) | 11.978.063 $ | 0,45 | 187.128 | |
| ResMed Inc. | ResMed Inc. | EC | 761152107 | Long | Börsenkurs (Stufe 1) | 11.669.025 $ | 0,44 | 59.878 | |
| Illumina, Inc. | Illumina, Inc. | EC | 452327109 | Long | Börsenkurs (Stufe 1) | 11.047.223 $ | 0,41 | 62.829 | |
| Veeva Systems Inc. | Veeva Systems Inc. | EC | 922475108 | Long | Börsenkurs (Stufe 1) | 10.943.333 $ | 0,41 | 61.663 | |
| DexCom, Inc. | DexCom, Inc. | EC | 252131107 | Long | Börsenkurs (Stufe 1) | 10.718.820 $ | 0,40 | 159.151 | |
| Mettler-Toledo International Inc. | Mettler-Toledo International Inc. | EC | 592688105 | Long | Börsenkurs (Stufe 1) | 10.699.146 $ | 0,40 | 8.375 | |
| West Pharmaceutical Services, Inc. | West Pharmaceutical Services, Inc. | EC | 955306105 | Long | Börsenkurs (Stufe 1) | 10.417.462 $ | 0,39 | 29.018 | |
| Moderna, Inc. | Moderna, Inc. | EC | 60770K107 | Long | Börsenkurs (Stufe 1) | 10.238.176 $ | 0,38 | 146.197 | |
| Quest Diagnostics Incorporated | Quest Diagnostics Incorporated | EC | 74834L100 | Long | Börsenkurs (Stufe 1) | 9.662.165 $ | 0,36 | 45.587 | |
| Labcorp Holdings Inc. | Labcorp Holdings Inc. | EC | 504922105 | Long | Börsenkurs (Stufe 1) | 9.454.480 $ | 0,35 | 33.766 | |
| Insmed Incorporated | Insmed Incorporated | EC | 457669307 | Long | Börsenkurs (Stufe 1) | 9.434.164 $ | 0,35 | 88.484 | |
| Steris Public Limited Company | Steris Public Limited Company | EC | IE00BFY8C754 | Long | Börsenkurs (Stufe 1) | 8.569.146 $ | 0,32 | 40.695 | |
| Royalty Pharma PLC | Royalty Pharma PLC | EC | GB00BMVP7Y09 | Long | Börsenkurs (Stufe 1) | 8.528.471 $ | 0,32 | 152.104 | |
| United Therapeutics Corporation | United Therapeutics Corporation | EC | 91307C102 | Long | Börsenkurs (Stufe 1) | 8.418.955 $ | 0,31 | 15.538 | |
| Guardant Health, Inc. | Guardant Health, Inc. | EC | 40131M109 | Long | Börsenkurs (Stufe 1) | 7.861.872 $ | 0,29 | 52.402 | |
| Incyte Corporation | Incyte Corporation | EC | 45337C102 | Long | Börsenkurs (Stufe 1) | 7.818.893 $ | 0,29 | 68.974 | |
| Viatris Inc. | Viatris Inc. | EC | 92556V106 | Long | Börsenkurs (Stufe 1) | 7.375.720 $ | 0,28 | 464.466 | |
| Roivant Sciences Ltd. | Roivant Sciences Ltd. | EC | BMG762791017 | Long | Börsenkurs (Stufe 1) | 7.286.730 $ | 0,27 | 205.898 | |
| Neurocrine Biosciences, Inc. | Neurocrine Biosciences, Inc. | EC | 64125C109 | Long | Börsenkurs (Stufe 1) | 6.938.754 $ | 0,26 | 41.171 | |
| Zimmer Biomet Holdings, Inc. | Zimmer Biomet Holdings, Inc. | EC | 98956P102 | Long | Börsenkurs (Stufe 1) | 6.882.035 $ | 0,26 | 79.940 | |
| Tenet Healthcare Corporation | Tenet Healthcare Corporation | EC | 88033G407 | Long | Börsenkurs (Stufe 1) | 6.593.635 $ | 0,25 | 35.245 | |
| Jazz Pharmaceuticals Public Limited Company | Jazz Pharmaceuticals Public Limited Company | EC | IE00B4Q5ZN47 | Long | Börsenkurs (Stufe 1) | 6.212.207 $ | 0,23 | 25.780 | |
| Cooper Companies, Inc., The | Cooper Companies, Inc., The | EC | 216648501 | Long | Börsenkurs (Stufe 1) | 5.774.878 $ | 0,22 | 80.531 | |
| Ionis Pharmaceuticals, Inc. | Ionis Pharmaceuticals, Inc. | EC | 462222100 | Long | Börsenkurs (Stufe 1) | 5.379.509 $ | 0,20 | 67.846 | |
| Revvity, Inc. | Revvity, Inc. | EC | 714046109 | Long | Börsenkurs (Stufe 1) | 5.137.653 $ | 0,19 | 46.177 | |
| Exelixis, Inc. | Exelixis, Inc. | EC | 30161Q104 | Long | Börsenkurs (Stufe 1) | 5.077.215 $ | 0,19 | 93.314 | |
| Bridgebio Pharma, Inc. | Bridgebio Pharma, Inc. | EC | 10806X102 | Long | Börsenkurs (Stufe 1) | 5.037.604 $ | 0,19 | 67.637 | |
| Medpace Holdings, Inc. | Medpace Holdings, Inc. | EC | 58506Q109 | Long | Börsenkurs (Stufe 1) | 4.942.663 $ | 0,18 | 9.333 | |
| Penumbra, Inc. | Penumbra, Inc. | EC | 70975L107 | Long | Börsenkurs (Stufe 1) | 4.921.280 $ | 0,18 | 15.586 | |
| Molina Healthcare, Inc. | Molina Healthcare, Inc. | EC | 60855R100 | Long | Börsenkurs (Stufe 1) | 4.847.525 $ | 0,18 | 21.196 | |
| Align Technology, Inc. | Align Technology, Inc. | EC | 016255101 | Long | Börsenkurs (Stufe 1) | 4.833.964 $ | 0,18 | 28.661 | |
| Elanco Animal Health Incorporated | Elanco Animal Health Incorporated | EC | 28414H103 | Long | Börsenkurs (Stufe 1) | 4.807.096 $ | 0,18 | 195.331 | |
| Solventum Corporation | Solventum Corporation | EC | 83444M101 | Long | Börsenkurs (Stufe 1) | 4.674.519 $ | 0,17 | 60.590 | |
| Bio-Techne Corporation | Bio-Techne Corporation | EC | 09073M104 | Long | Börsenkurs (Stufe 1) | 4.587.163 $ | 0,17 | 64.928 | |
| BioMarin Pharmaceutical Inc. | BioMarin Pharmaceutical Inc. | EC | 09061G101 | Long | Börsenkurs (Stufe 1) | 4.546.015 $ | 0,17 | 79.448 | |
| Baxter International Inc. | Baxter International Inc. | EC | 071813109 | Long | Börsenkurs (Stufe 1) | 4.516.002 $ | 0,17 | 211.820 | |
| Charles River Laboratories International, Inc. | Charles River Laboratories International, Inc. | EC | 159864107 | Long | Börsenkurs (Stufe 1) | 4.456.197 $ | 0,17 | 19.649 | |
| Cytokinetics, Incorporated | Cytokinetics, Incorporated | EC | 23282W605 | Long | Börsenkurs (Stufe 1) | 4.354.487 $ | 0,16 | 51.115 | |
| Insulet Corporation | Insulet Corporation | EC | 45784P101 | Long | Börsenkurs (Stufe 1) | 4.341.561 $ | 0,16 | 28.516 | |
| Brightspring Health Services, Inc. | Brightspring Health Services, Inc. | EC | 10950A106 | Long | Börsenkurs (Stufe 1) | 4.312.722 $ | 0,16 | 61.840 | |
| Axsome Therapeutics, Inc. | Axsome Therapeutics, Inc. | EC | 05464T104 | Long | Börsenkurs (Stufe 1) | 4.241.375 $ | 0,16 | 17.328 | |
| Canticle Pharmaceuticals, Inc. | Canticle Pharmaceuticals, Inc. | EC | 558868105 | Long | Börsenkurs (Stufe 1) | 4.236.536 $ | 0,16 | 7.890 | |
| Medline Inc. | Medline Inc. | EC | 58507V107 | Long | Börsenkurs (Stufe 1) | 4.221.382 $ | 0,16 | 107.033 | |
| Encompass Health Corporation | Encompass Health Corporation | EC | 29261A100 | Long | Börsenkurs (Stufe 1) | 4.125.075 $ | 0,15 | 40.810 | |
| Arrowhead Pharmaceuticals Inc | Arrowhead Pharmaceuticals Inc | EC | 04280A100 | Long | Börsenkurs (Stufe 1) | 4.104.436 $ | 0,15 | 50.355 | |
| Krystal Biotech, Inc. | Krystal Biotech, Inc. | EC | 501147102 | Long | Börsenkurs (Stufe 1) | 3.879.120 $ | 0,14 | 10.437 | |
| Ensign Group, Inc., The | Ensign Group, Inc., The | EC | 29358P101 | Long | Börsenkurs (Stufe 1) | 3.859.223 $ | 0,14 | 24.075 | |
| Halozyme Therapeutics, Inc. | Halozyme Therapeutics, Inc. | EC | 40637H109 | Long | Börsenkurs (Stufe 1) | 3.839.065 $ | 0,14 | 49.049 | |
| Globus Medical, Inc. | Globus Medical, Inc. | EC | 379577208 | Long | Börsenkurs (Stufe 1) | 3.646.074 $ | 0,14 | 46.147 | |
| Corcept Therapeutics Incorporated | Corcept Therapeutics Incorporated | EC | 218352102 | Long | Börsenkurs (Stufe 1) | 3.494.347 $ | 0,13 | 40.188 | |
| Alkermes Public Limited Company | Alkermes Public Limited Company | EC | IE00B56GVS15 | Long | Börsenkurs (Stufe 1) | 3.410.024 $ | 0,13 | 65.083 | |
| AptarGroup, Inc. | AptarGroup, Inc. | EC | 038336103 | Long | Börsenkurs (Stufe 1) | 3.289.880 $ | 0,12 | 26.277 | |
| TG Therapeutics, Inc. | TG Therapeutics, Inc. | EC | 88322Q108 | Long | Börsenkurs (Stufe 1) | 3.280.907 $ | 0,12 | 59.718 | |
| Glaukos Corporation | Glaukos Corporation | EC | 377322102 | Long | Börsenkurs (Stufe 1) | 3.252.495 $ | 0,12 | 23.272 | |
| Henry Schein, Inc. | Henry Schein, Inc. | EC | 806407102 | Long | Börsenkurs (Stufe 1) | 3.232.558 $ | 0,12 | 38.704 | |
| Davita Inc. | Davita Inc. | EC | 23918K108 | Long | Börsenkurs (Stufe 1) | 3.160.773 $ | 0,12 | 14.207 | |
| Universal Health Services, Inc. | Universal Health Services, Inc. | EC | 913903100 | Long | Börsenkurs (Stufe 1) | 3.144.199 $ | 0,12 | 21.146 | |
| HealthEquity, Inc. | HealthEquity, Inc. | EC | 42226A107 | Long | Börsenkurs (Stufe 1) | 3.111.343 $ | 0,12 | 34.448 | |
| Vaxcyte, Inc. | Vaxcyte, Inc. | EC | 92243G108 | Long | Börsenkurs (Stufe 1) | 3.062.463 $ | 0,11 | 52.683 | |
| Repligen Corporation | Repligen Corporation | EC | 759916109 | Long | Börsenkurs (Stufe 1) | 2.981.350 $ | 0,11 | 21.851 | |
| Praxis Precision Medicines, Inc. | Praxis Precision Medicines, Inc. | EC | 74006W207 | Long | Börsenkurs (Stufe 1) | 2.978.627 $ | 0,11 | 8.897 | |
| Lantheus Holdings, Inc. | Lantheus Holdings, Inc. | EC | 516544103 | Long | Börsenkurs (Stufe 1) | 2.975.078 $ | 0,11 | 26.817 | |
| Hims & Hers Health, Inc. | Hims & Hers Health, Inc. | EC | 433000106 | Long | Börsenkurs (Stufe 1) | 2.908.050 $ | 0,11 | 83.878 | |
| Nuvalent, Inc. | Nuvalent, Inc. | EC | 670703107 | Long | Börsenkurs (Stufe 1) | 2.834.325 $ | 0,11 | 22.950 | |
| Spyre Therapeutics, Inc. | Spyre Therapeutics, Inc. | EC | 00773J202 | Long | Börsenkurs (Stufe 1) | 2.812.284 $ | 0,11 | 31.677 | |
| Tempus AI, Inc. | Tempus AI, Inc. | EC | 88023B103 | Long | Börsenkurs (Stufe 1) | 2.746.867 $ | 0,10 | 47.417 | |
| Protagonist Therapeutics, Inc. | Protagonist Therapeutics, Inc. | EC | 74366E102 | Long | Börsenkurs (Stufe 1) | 2.674.450 $ | 0,10 | 21.818 | |
| Avantor, Inc. | Avantor, Inc. | EC | 05352A100 | Long | Börsenkurs (Stufe 1) | 2.667.070 $ | 0,10 | 269.401 | |
| Oscar Health, Inc. | Oscar Health, Inc. | EC | 687793109 | Long | Börsenkurs (Stufe 1) | 2.635.162 $ | 0,10 | 92.397 | |
| Kymera Therapeutics, Inc. | Kymera Therapeutics, Inc. | EC | 501575104 | Long | Börsenkurs (Stufe 1) | 2.571.016 $ | 0,10 | 22.421 | |
| Bruker Corporation | Bruker Corporation | EC | 116794108 | Long | Börsenkurs (Stufe 1) | 2.569.144 $ | 0,10 | 42.691 | |
| Chemed Corporation | Chemed Corporation | EC | 16359R103 | Long | Börsenkurs (Stufe 1) | 2.557.844 $ | 0,10 | 5.492 | |
| Ligand Pharmaceuticals Incorporated | Ligand Pharmaceuticals Incorporated | EC | 53220K504 | Long | Börsenkurs (Stufe 1) | 2.507.858 $ | 0,09 | 7.934 | |
| PTC Therapeutics, Inc. | PTC Therapeutics, Inc. | EC | 69366J200 | Long | Börsenkurs (Stufe 1) | 2.476.791 $ | 0,09 | 30.364 | |
| Cogent Biosciences, Inc. | Cogent Biosciences, Inc. | EC | 19240Q201 | Long | Börsenkurs (Stufe 1) | 2.472.620 $ | 0,09 | 63.892 | |
| Rhythm Pharmaceuticals, Inc. | Rhythm Pharmaceuticals, Inc. | EC | 76243J105 | Long | Börsenkurs (Stufe 1) | 2.447.101 $ | 0,09 | 22.040 | |
| Teleflex Incorporated | Teleflex Incorporated | EC | 879369106 | Long | Börsenkurs (Stufe 1) | 2.317.680 $ | 0,09 | 18.284 | |
| Apogee Therapeutics, Inc. | Apogee Therapeutics, Inc. | EC | 03770N101 | Long | Börsenkurs (Stufe 1) | 2.197.080 $ | 0,08 | 16.553 | |
| Bio-Rad Laboratories, Inc. | Bio-Rad Laboratories, Inc. | EC | 090572207 | Long | Börsenkurs (Stufe 1) | 2.175.650 $ | 0,08 | 7.410 | |
| Mirum Pharmaceuticals, Inc. | Mirum Pharmaceuticals, Inc. | EC | 604749101 | Long | Börsenkurs (Stufe 1) | 2.120.021 $ | 0,08 | 18.109 | |
| CRISPR Therapeutics AG | CRISPR Therapeutics AG | EC | CH0334081137 | Long | Börsenkurs (Stufe 1) | 2.073.065 $ | 0,08 | 38.010 | |
| Scholar Rock Holding Corporation | Scholar Rock Holding Corporation | EC | 80706P103 | Long | Börsenkurs (Stufe 1) | 1.972.740 $ | 0,07 | 35.868 | |
| Indivior Pharmaceuticals, Inc. | Indivior Pharmaceuticals, Inc. | EC | 45579U109 | Long | Börsenkurs (Stufe 1) | 1.919.178 $ | 0,07 | 46.775 | |
| Sotera Health LLC | Sotera Health LLC | EC | 83601L102 | Long | Börsenkurs (Stufe 1) | 1.785.881 $ | 0,07 | 100.613 | |
| Alignment Healthcare, Inc. | Alignment Healthcare, Inc. | EC | 01625V104 | Long | Börsenkurs (Stufe 1) | 1.743.797 $ | 0,07 | 73.238 | |
| Viking Therapeutics, Inc. | Viking Therapeutics, Inc. | EC | 92686J106 | Long | Börsenkurs (Stufe 1) | 1.733.292 $ | 0,06 | 44.432 | |
| RadNet, Inc. | RadNet, Inc. | EC | 750491102 | Long | Börsenkurs (Stufe 1) | 1.724.417 $ | 0,06 | 27.962 | |
| Envista Holdings Corporation | Envista Holdings Corporation | EC | 29415F104 | Long | Börsenkurs (Stufe 1) | 1.719.970 $ | 0,06 | 65.274 | |
| Merit Medical Systems, Inc. | Merit Medical Systems, Inc. | EC | 589889104 | Long | Börsenkurs (Stufe 1) | 1.715.680 $ | 0,06 | 24.743 | |
| CG Oncology, Inc. | CG Oncology, Inc. | EC | 156944100 | Long | Börsenkurs (Stufe 1) | 1.650.918 $ | 0,06 | 23.236 | |
| Irhythm Holdings, Inc. | Irhythm Holdings, Inc. | EC | 450056106 | Long | Börsenkurs (Stufe 1) | 1.635.087 $ | 0,06 | 13.746 | |
| Crinetics Pharmaceuticals, Inc. | Crinetics Pharmaceuticals, Inc. | EC | 22663K107 | Long | Börsenkurs (Stufe 1) | 1.574.746 $ | 0,06 | 42.083 | |
| Dianthus Therapeutics, Inc. | Dianthus Therapeutics, Inc. | EC | 252828108 | Long | Börsenkurs (Stufe 1) | 1.517.764 $ | 0,06 | 15.570 | |
| Immunitybio, Inc. | Immunitybio, Inc. | EC | 45256X103 | Long | Börsenkurs (Stufe 1) | 1.350.599 $ | 0,05 | 154.266 | |
| Immunovant, Inc. | Immunovant, Inc. | EC | 45258J102 | Long | Börsenkurs (Stufe 1) | 1.350.515 $ | 0,05 | 35.051 | |
| Waystar Holding Corp. | Waystar Holding Corp. | EC | 946784105 | Long | Börsenkurs (Stufe 1) | 1.140.996 $ | 0,04 | 55.577 | |
| Celcuity Inc. | Celcuity Inc. | EC | 15102K100 | Long | Börsenkurs (Stufe 1) | 946.706 $ | 0,04 | 9.049 | |
| PACS Group, Inc. | PACS Group, Inc. | EC | 69380Q107 | Long | Börsenkurs (Stufe 1) | 809.179 $ | 0,03 | 18.977 | |
| Summit Therapeutics Sub Inc. | Summit Therapeutics Sub Inc. | EC | 86627T108 | Long | Börsenkurs (Stufe 1) | 800.374 $ | 0,03 | 54.933 | |
| Caris Life Sciences, Inc. | Caris Life Sciences, Inc. | EC | 142152107 | Long | Börsenkurs (Stufe 1) | 776.934 $ | 0,03 | 43.599 | |
| Akero Therapeutics Inc. | Akero Therapeutics Inc. | EC | Long | Schätzwert (Stufe 3) | 18.841 $ | 0,00 | 28.986 | ||
| Gesamt | 2.667.948.682 $ | 99,63 | 18.131.099 |
Keine Anlageberatung, keine individuelle Empfehlung.
Die hier gezeigten Zahlen sind eine aggregierte Auswertung öffentlich zugänglicher
aufsichtsrechtlicher Pflichtmeldungen und öffentlicher Register und stellen keine
Bewertung oder Empfehlung zu einzelnen Wertpapieren, Fonds oder Emittenten dar.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Interessenkonflikte: Der Betreiber kann über verlinkte Anbieter (z. B. Broker) Affiliate-Vergütungen erhalten und ggf. eigene Positionen in genannten Werten halten. Methodik: Berechnungsgrundlagen.
Keine Anlageberatung, keine individuelle Empfehlung.
Aggregierte Auswertung öffentlicher Pflichtmeldungen, keine Bewertung einzelner
Wertpapiere. Der Betreiber kann über verlinkte Anbieter Affiliate-Vergütungen
erhalten und ggf. eigene Positionen halten.
Rechtliche Hinweise.